神经信号通路
选项
-
L(+)棕榈酸抗坏血酸酯分子式: C22H38O7 分子量: 414.53IUPAC Name: [(2S)-2-[(2R)-3,4-dihydroxy-5-oxo-2H-furan-2-yl]-2-hydroxyethyl] hexadecanoateSMILES: CCCCCCCCCCCCCCCC(=O)OCC(C1C(=C(C(=O)O1)O)O)OInChIKey: QAQJMLQRFWZOBN-LAUBAEHRSA-NInChI: 1S/C22H38O7/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(24)28-16-17(23)21-19(25)20(26)22(27)29-21/h17,21,23,25-26H,2-16H2,1H3/t17-,21+/m0/s1
-
Bapineuzumab (anti-APP)关联靶标: APP
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 648895-38-9 -
Aducanumab (anti-APP)关联靶标: APP
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1384260-65-4 -
Erenumab (anti-CALCRL)
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2Sa; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG2SA
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1582205-90-0 -
Eptinezumab (anti-CGRP)
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 大鼠(Rat)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1644539-04-7 -
Simtuzumab (anti-LOXL2)关联靶标: LOXL2
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG4SP
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1318075-13-6 -
Rovalpituzumab (anti-DLL3)关联靶标: DLL3
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1613313-01-1 -
Fremanezumab (anti-CALCA)
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<0.01EU/μg; Human IgG2SA; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG2SA
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1655501-53-3 -
Fulranumab (anti-NGF)关联靶标: NGF
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG2; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG2
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 902141-80-4 -
Gantenerumab (anti-Amyloid Beta)关联靶标: APP
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1043556-46-2 -
Solanezumab (anti-Amyloid Beta)关联靶标: APP
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 955085-14-0 -
Brontictuzumab (anti-NOTCH1)关联靶标: NOTCH1
- 简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG2SA; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 小鼠(Mouse)
- 亚型: Human IgG2SA
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1447814-75-6
首页
400-620-6333











